These medications are not licensed or recommended by NICE, the MHRA, or other UK regulatory bodies for cognitive impairment or dementia
In this context, future directions refers not only to investigational agents but also to advances beyond single-hormone therapies, including multimodal approaches, innovative formulations, and the integration of these treatments into long-term management of obesity as a chronic disease
Knee and hip pain improve significantly in users with obesity-related osteoarthritis
Always follow recommended daily intake guidelines
This window is when your body is making the biggest adjustment to the medication's appetite-suppressing and glucose-regulating effects
Yes, many patients successfully perform high intensity interval training on GLP-1 medications